Patents by Inventor Tomoko Morimoto

Tomoko Morimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF
    Publication number: 20220016215
    Abstract: The present disclosure provides GIF receptor agonist peptide compounds having an activating action on GIF receptors and use of the GIF receptor agonist peptide as a medicament for the treatment and/or prevention of emesis. Specifically, a GIF receptor agonist peptide containing a sequence represented by the formula (I) or a salt thereof, and a medicament comprising the same are N provided. Formula (I) P1-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15-A16-A17-A18-A19-A20-A21-A22-A23-A24-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-A37-A38-A39-A40-A41-A42-P2, wherein each symbol is as defined herein, with the proviso that the GIF receptor agonist peptide is not native human GIF having an amino acid sequence as set forth in SEQ ID NO: 1.
    Type: Application
    Filed: September 24, 2019
    Publication date: January 20, 2022
    Inventors: Shiro TAKEKAWA, Tomoko MORIMOTO, Minoru MARUYAMA, Hiroaki NAGAI, Akira TANAKA, Hisanori MATSUI, Atsuko OBINATA, Derek Cecil COLE, Mack FLINSPACH, Nick SCORAH, Abhijit Suresh BHAT
  • Peptide compound
    Patent number: 11174301
    Abstract: The present invention provides a novel peptide compound having an activating action on GIP receptors and use of the peptide compound as a medicament. Specifically, a peptide containing a sequence represented by the formula (I) or a salt thereof and a medicament comprising the same are provided. P1-Tyr-A2-Glu-Gly-Thr-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15-A16-A17-A18-A19-A20-A21-A22-A23-A24-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-A37-A38-A39-A40-P2?? (I) wherein each symbol is as defined herein.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: November 16, 2021
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Taiji Asami, Naoki Nishizawa, Ayumu Niida, Yoko Kanematsu, Mari Adachi, Shiro Takekawa, Tomoko Morimoto
  • PEPTIDE COMPOUND
    Publication number: 20200140505
    Abstract: The present invention provides a novel peptide compound having an activating action on GIP receptors and use of the peptide compound as a medicament. Specifically, a peptide containing a sequence represented by the formula (I) or a salt thereof and a medicament comprising the same are provided. P1-Tyr-A2-Glu-Gly-Thr-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15-A16-A17-A18-A19-A20-A21-A22-A23-A24-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-A37-A38-A39-A40-P2?? (I) wherein each symbol is as defined herein.
    Type: Application
    Filed: August 29, 2019
    Publication date: May 7, 2020
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMTED
    Inventors: TAIJI ASAMI, NAOKI NISHIZAWA, AYUMU NIIDA, YOKO KANEMATSU, MARI ADACHI, SHIRO TAKEKAWA, TOMOKO MORIMOTO
  • Peptide compound
    Patent number: 10435445
    Abstract: The present invention provides a novel peptide compound having an activating action on GIP receptors and use of the peptide compound as a medicament. Specifically, a peptide containing a sequence represented by the formula (I) or a salt thereof and a medicament comprising the same are provided. (I) P1-Tyr-A2-Glu-Gly-Thr-A6-A7-A8-A9-A10-A11-A12-A13- A14-A15-A16-A17-A18-A19-A20-A21-A22-A23-A24-A25- A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-A37- A38-A39-A40-P2 wherein each symbol is as defined herein.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: October 8, 2019
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Taiji Asami, Naoki Nishizawa, Ayumu Niida, Yoko Kanematsu, Mari Adachi, Shiro Takekawa, Tomoko Morimoto
  • PEPTIDE COMPOUND
    Publication number: 20180298070
    Abstract: The present invention provides a novel peptide compound having an activating action on GIP receptors and use of the peptide compound as a medicament. Specifically, a peptide containing a sequence represented by the formula (I) or a salt thereof and a medicament comprising the same are provided. P1-Tyr-A2-Glu-Gly-Thr-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15-A16-A17-A18-A19-A20-A21-A22-A23-A24-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-A37-A38-A39-A40-P2 ??(I) wherein each symbol is as defined herein.
    Type: Application
    Filed: March 30, 2018
    Publication date: October 18, 2018
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Taiji Asami, Naoki Nishizawa, Ayumu Niida, Yoko Kanematsu, Mari Adachi, Shiro Takekawa, Tomoko Morimoto